Neos Therapeutics, Inc

(NASDAQ:NEOS)

Latest On Neos Therapeutics, Inc (NEOS):

Date/Time Type Description Signal Details
2021-03-18 23:23 ESTNewsHEXO, CSIQ, LAZR and SIG among premarket gainersN/A
2021-01-06 16:17 ESTFinancialsCompany financials have been released.Neutral
2021-01-01 12:21 ESTAnalyst RatingThe Analyst Target Price has decreased from $2 to $1.Neutral
2020-12-29 12:12 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.5 to $2.Neutral
2020-12-14 00:19 ESTAnalyst RatingThe Analyst Target Price has increased from $4.67 to $6.5.Buy
2020-12-11 12:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.5 to $4.67.Neutral
2020-12-10 15:44 ESTNewsAytu BioScience buying Neos Therapeutics for $44.9M in stockN/A
2020-11-26 20:57 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 12:23 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.75 to $5.5.Neutral
2020-11-12 04:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 04:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 12:39 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.75 to $5.75.Neutral
2020-11-09 14:56 ESTNewsNeos Therapeutics EPS misses by $0.05, misses on revenueN/A
2020-11-09 14:53 ESTNewsNeos Therapeutics' (NEOS) CEO Jerry McLaughlin on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-07 16:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 13:30 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-15 01:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:34 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 21:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $7 to $6.75.Neutral
2020-08-10 18:15 ESTNewsNeos Therapeutics EPS beats by $0.02, beats on revenueN/A
2020-08-10 18:14 ESTNewsNeos Therapeutics, Inc. (NEOS) CEO Jerry McLaughlin on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-06 13:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:12 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-15 19:34 ESTNewsNeos Therapeutics Is Hitting A Considerable Air PocketN/A
2020-07-09 09:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:14 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:27 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:10 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:32 ESTFinancialsCompany financials have been released.Neutral
2020-06-11 21:11 ESTInsider TradeBryant Fong has directly acquired 23,453 shares and currently holds 24,953 shares.Buy
2020-06-11 21:11 ESTInsider TradeBeth Hecht has directly acquired 23,453 shares and currently holds 23,453 shares.Buy
2020-06-11 21:11 ESTInsider TradeALAN L HELLER has directly acquired 23,453 shares and currently holds 446,819 shares.Buy
2020-06-11 21:11 ESTInsider TradeJames A. Jr. Robinson has directly acquired 23,453 shares and currently holds 23,453 shares.Buy
2020-06-11 21:10 ESTInsider TradeGREGORY J ROBITAILLE has directly acquired 23,453 shares and currently holds 79,130 shares.Buy
2020-06-11 21:10 ESTInsider TradeJohn P. Schmid has directly acquired 23,453 shares and currently holds 23,453 shares.Buy
2020-06-11 21:10 ESTInsider TradeLinda M Szyper has directly acquired 23,453 shares and currently holds 23,453 shares.Buy
2020-06-02 09:14 ESTEarnings EstimateAn EPS average of -$0.04 is estimated for the quarter ending on September 30, 2020.Buy
2020-05-27 05:39 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 20:58 ESTFinancialsCompany financials have been released.Neutral
2020-05-11 23:35 ESTNewsNeos Therapeutics EPS misses by $0.07, misses on revenueN/A
2020-05-11 23:35 ESTNewsNeos Therapeutics. Inc. (NEOS) CEO Jerry McLaughlin on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-06 05:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:16 ESTFinancialsCompany financials have been released.Neutral
2020-04-29 06:26 ESTNewsNeos Therapeutics: Failure To Re-LaunchN/A
2020-04-12 04:12 ESTNewsNeos Therapeutics EPS misses by $0.04, misses on revenueN/A

About Neos Therapeutics, Inc (NEOS):

Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate to treat ADHD; Adzenys ER amphetamine for the treatment of ADHD; and generic Tussionex, a hydrocodone and chlorpheniramine polistirex XR oral suspension for cough and upper respiratory symptoms of a cold. It also offers NT0502, a clinical-stage product candidate that has completed Phase I pilot pharmacokinetic trial for the treatment of neurological conditions associated with excessive salivation and drooling to reduce chronic sialorrhea in patients. The company was incorporated in 2009 and is headquartered in Grand Prairie, Texas.

NEOS Quotes by TradingView

See Advanced Chart

General

  • Name Neos Therapeutics, Inc
  • Symbol NEOS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 213
  • Fiscal Year EndDecember
  • IPO Date2015-07-23
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.neostx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 0.8
  • Enterprise Value Revenue 1.35
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin -38%
  • Operating Margin -24%
  • Return on Assets -11%
  • Revenue 56.99 million
  • Earnings Per Share -$0.78
  • Revenue Per Share $1.15
  • Gross Profit 39.53 million
  • Quarterly Earnings Growth -28.5%
View More

Highlights

  • Market Capitalization 65.19 million
  • EBITDA -22108000
  • PEG Ratio -0.02
  • Analyst Target Price $1
  • Book Value Per Share -$0.03
View More

Share Statistics

  • Shares Outstanding 49.76 million
  • Shares Float 44.26 million
  • % Held by Insiders 150%
  • % Held by Institutions 33.38%
  • Shares Short 1.17 million
  • Shares Short Prior Month 1.29 million
  • Short Ratio 0.24
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.45
  • 52 Week High $1.68
  • 52 Week Low $0.45
  • 50 Day Moving Average 0.94
  • 200 Day Moving Average 0.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Neos Therapeutics, Inc (NEOS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Neos Therapeutics, Inc (NEOS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$12.54 million-$0.10-$0.05-87.62%
2020-06-302020-08-10$N/A-$0.11-$0.1315.38%
2020-03-312020-05-11$14.49 million-$0.16-$0.09-72.97%
2019-12-312020-03-13$16.83 million-$0.07-$0.03-115.38%
2019-09-302019-11-08$17.54 million-$0.04-$0.1164.44%
2019-06-302019-08-08$15.64 million-$0.08-$0.1752.38%
2019-03-312019-05-09$14.63 million-$0.15-$0.2025%
2018-12-312019-03-14$15.39 million-$0.23-$0.2817.27%
2018-09-302018-11-09$12.5 million-$0.43-$0.41-3.86%
2018-06-302018-08-08$11.36 million-$0.52-$0.44-18.18%
2018-03-312018-05-09$10.73 million-$0.50-$0.49-1.52%
2017-12-312018-03-15$7.79 million-$0.49-$0.6119.49%
2017-09-302017-11-08$7.1 million-$0.58-$0.7522.47%
2017-06-302017-08-08$5.18 million-$0.83-$0.830.29%
2017-03-312017-05-09$5.63 million-$0.87-$0.925.72%
2016-12-312017-03-14$3.5 million-$1.14-$1.3616.29%
2016-09-302016-11-10$1.58 million-$1.61-$1.641.6%
2016-06-302016-08-11$1.49 million-$1.65-$1.37-20.81%
2016-03-312016-05-16$2.58 million-$0.79-$0.835.04%
2015-12-312016-03-17$1.66 million-$0.57-$0.7119.75%
2015-09-302015-11-13$221000-$0.77-$0.57-35.09%
2015-06-302015-07-28$1.48 million-$7.76-$4.53-71.3%

Neos Therapeutics, Inc (NEOS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Neos Therapeutics, Inc (NEOS) Chart:

Neos Therapeutics, Inc (NEOS) News:

Below you will find a list of latest news for Neos Therapeutics, Inc (NEOS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Neos Therapeutics, Inc (NEOS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Neos Therapeutics, Inc (NEOS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020007668/0001558370-20-007668-index.htm
2018-12-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1467652/000000000018038312/0000000000-18-038312-index.htm
2019-03-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1467652/000000000019005435/0000000000-19-005435-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000003877719000051/0000038777-19-000051-index.htm
2018-12-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000021545718007272/0000215457-18-007272-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000021545719006788/0000215457-19-006788-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000021545719008350/0000215457-19-008350-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000076999320000083/0000769993-20-000083-index.htm
2019-01-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000091957419000044/0000919574-19-000044-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000091957420001155/0000919574-20-001155-index.htm
2018-11-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000093583618000600/0000935836-18-000600-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000093583619000095/0000935836-19-000095-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000093583620000115/0000935836-20-000115-index.htm
2018-11-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1467652/000104746918007052/0001047469-18-007052-index.htm
2018-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1467652/000104746918007053/0001047469-18-007053-index.htm
2018-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1467652/000104746918007085/0001047469-18-007085-index.htm
2018-12-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1467652/000104746918007597/0001047469-18-007597-index.htm
2018-12-20424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1467652/000104746918007758/0001047469-18-007758-index.htm
2019-03-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1467652/000104746919001344/0001047469-19-001344-index.htm
2019-03-18S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1467652/000104746919001351/0001047469-19-001351-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1467652/000104746919002545/0001047469-19-002545-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1467652/000104746920002475/0001047469-20-002475-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000110465918031930/0001104659-18-031930-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918041805/0001104659-18-041805-index.htm
2018-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918042601/0001104659-18-042601-index.htm
2018-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918042931/0001104659-18-042931-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918042932/0001104659-18-042932-index.htm
2018-07-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043554/0001104659-18-043554-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043858/0001104659-18-043858-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043859/0001104659-18-043859-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043860/0001104659-18-043860-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043861/0001104659-18-043861-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043862/0001104659-18-043862-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918043863/0001104659-18-043863-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918050322/0001104659-18-050322-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000110465918050753/0001104659-18-050753-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918063669/0001104659-18-063669-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918066013/0001104659-18-066013-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918066376/0001104659-18-066376-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918066858/0001104659-18-066858-index.htm
2018-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918066979/0001104659-18-066979-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918067139/0001104659-18-067139-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000110465918067395/0001104659-18-067395-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918070734/0001104659-18-070734-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918071882/0001104659-18-071882-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918072099/0001104659-18-072099-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918072389/0001104659-18-072389-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465918072812/0001104659-18-072812-index.htm
2018-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1467652/000110465918073569/0001104659-18-073569-index.htm
2018-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465918074634/0001104659-18-074634-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465919004302/0001104659-19-004302-index.htm
2019-01-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919004505/0001104659-19-004505-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919004506/0001104659-19-004506-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919012421/0001104659-19-012421-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919012433/0001104659-19-012433-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465919014712/0001104659-19-014712-index.htm
2019-03-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919015421/0001104659-19-015421-index.htm
2019-03-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919016881/0001104659-19-016881-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919016882/0001104659-19-016882-index.htm
2019-03-224/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919016914/0001104659-19-016914-index.htm
2019-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1467652/000110465919023426/0001104659-19-023426-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1467652/000110465919024521/0001104659-19-024521-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465919028001/0001104659-19-028001-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000110465919028440/0001104659-19-028440-index.htm
2019-06-173/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035979/0001104659-19-035979-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035980/0001104659-19-035980-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035981/0001104659-19-035981-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035982/0001104659-19-035982-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035983/0001104659-19-035983-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035984/0001104659-19-035984-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035985/0001104659-19-035985-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465919035986/0001104659-19-035986-index.htm
2019-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465919036179/0001104659-19-036179-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000110465919052850/0001104659-19-052850-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920020220/0001104659-20-020220-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920029264/0001104659-20-029264-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920029267/0001104659-20-029267-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920029269/0001104659-20-029269-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920034240/0001104659-20-034240-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1467652/000110465920049205/0001104659-20-049205-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072544/0001104659-20-072544-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072546/0001104659-20-072546-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072548/0001104659-20-072548-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072549/0001104659-20-072549-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072550/0001104659-20-072550-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072551/0001104659-20-072551-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1467652/000110465920072552/0001104659-20-072552-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000114420419007732/0001144204-19-007732-index.htm
2019-07-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000117891319001797/0001178913-19-001797-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000117891320000339/0001178913-20-000339-index.htm
2018-11-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000119380518001313/0001193805-18-001313-index.htm
2018-11-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1467652/000119380518001380/0001193805-18-001380-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837019007584/0001558370-19-007584-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000155837019007801/0001558370-19-007801-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837019010498/0001558370-19-010498-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000155837019010615/0001558370-19-010615-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020002616/0001558370-20-002616-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1467652/000155837020002684/0001558370-20-002684-index.htm
2020-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1467652/000155837020002685/0001558370-20-002685-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020003315/0001558370-20-003315-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020003737/0001558370-20-003737-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020004217/0001558370-20-004217-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020005576/0001558370-20-005576-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020006257/0001558370-20-006257-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000155837020006303/0001558370-20-006303-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020007211/0001558370-20-007211-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020007454/0001558370-20-007454-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020007668/0001558370-20-007668-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1467652/000155837020010035/0001558370-20-010035-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1467652/000155837020010196/0001558370-20-010196-index.htm
2018-12-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1467652/999999999518003187/9999999995-18-003187-index.htm
2019-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1467652/999999999519000975/9999999995-19-000975-index.htm
2019-04-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1467652/999999999719002229/9999999997-19-002229-index.htm

Neos Therapeutics, Inc (NEOS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neos Therapeutics, Inc (NEOS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 150%
Institutional Ownership: 3338%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Richard I EisenstadtChief Financial OfficerBuy100,000.000.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920029264/0001104659-20-029264-index.htm
2020-03-02John M LimongelliSVP & General CounselBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920029269/0001104659-20-029269-index.htm
2020-06-10Beth HechtDirectorBuy23,453.0023,453.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072546/0001104659-20-072546-index.htm
2020-06-10James A. Jr. RobinsonDirectorBuy23,453.0023,453.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072549/0001104659-20-072549-index.htm
2020-06-10John P. SchmidDirectorBuy23,453.0023,453.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072551/0001104659-20-072551-index.htm
2020-06-10Linda M SzyperDirectorBuy23,453.0023,453.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072552/0001104659-20-072552-index.htm
2018-12-06Gerald W. McLaughlinChief Executive OfficerBuy17,097.002.1136,119.1224,500.00https://www.sec.gov/Archives/edgar/data/1467652/000110465918072099/0001104659-18-072099-index.htm
2020-06-10Bryant FongDirectorBuy23,453.0024,953.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072544/0001104659-20-072544-index.htm
2020-03-02Gerald W. McLaughlinChief Executive OfficerBuy290,000.00314,500.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920029267/0001104659-20-029267-index.htm
2018-11-08ALAN L HELLERDirectorBuy43,478.002.3099,999.40423,366.00https://www.sec.gov/Archives/edgar/data/1467652/000110465918066979/0001104659-18-066979-index.htm
2018-12-12Richard I EisenstadtChief Financial OfficerBuy5,000.002.1610,819.5042,460.00https://www.sec.gov/Archives/edgar/data/1467652/000110465918072812/0001104659-18-072812-index.htm
2020-06-10ALAN L HELLERDirectorBuy23,453.00446,819.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072548/0001104659-20-072548-index.htm
2018-12-04Gerald W. McLaughlinChief Executive OfficerBuy7,403.002.0415,119.897,403.00https://www.sec.gov/Archives/edgar/data/1467652/000110465918071882/0001104659-18-071882-index.htm
2020-06-10GREGORY J ROBITAILLEDirectorBuy23,453.0079,130.00https://www.sec.gov/Archives/edgar/data/1467652/000110465920072550/0001104659-20-072550-index.htm